• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清免疫球蛋白 A 浓度是非酒精性脂肪性肝炎肝硬化前阶段肝纤维化的独立预测因子。

Serum immunoglobulin a concentration is an independent predictor of liver fibrosis in nonalcoholic steatohepatitis before the cirrhotic stage.

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

出版信息

Dig Dis Sci. 2011 Dec;56(12):3648-54. doi: 10.1007/s10620-011-1771-2. Epub 2011 Jun 15.

DOI:10.1007/s10620-011-1771-2
PMID:21674175
Abstract

BACKGROUND AND AIMS

The similarity of alcoholic liver disease and nonalcoholic steatohepatitis (NASH) in terms of pathogenic mechanisms suggests that immunoglobulin A (IgA) may play an important role in the pathogenesis of NASH. We aimed to determine whether serum IgA concentrations allow a diagnosis of liver fibrosis in NASH.

METHODS

We compared serum IgA concentrations between 108 patients with stages 0-2 NASH and 19 patients with stage 3 NASH.

RESULTS

In a univariate analysis, age (P < 0.0001), gender (P = 0.0039), serum albumin level (P = 0.0192), AST (P < 0.0001), AST/ALT ratio (P < 0.0001), platelet count (P = 0.0027), hyaluronic acid level (P < 0.0001), fasting blood sugar (FBS) (P = 0.0013), IRI (P = 0.0001), prothrombin time (%) (P = 0.0287), IgA (P < 0.0001), total sum of IgG, IgA, and IgM (P = 0.0049), and IgA/(IgG + IgA + IgM) (P = 0.0105) were significantly elevated in severe-stage NASH patients compared with the early-stage NASH group. Multiple logistic regression analysis showed that in severe-stage NASH patients, only serum IgA concentrations were significantly elevated (P = 0.0225) relative to early-stage NASH patients. The area under the curve (AUC) of serum IgA concentrations was 0.758 for detecting severe-stage NASH compared with early-stage NASH.

CONCLUSIONS

Serum IgA concentration could be a useful independent predictor for assessing the pre-cirrhotic progression of NASH.

摘要

背景与目的

酒精性肝病和非酒精性脂肪性肝炎(NASH)在发病机制上具有相似性,提示免疫球蛋白 A(IgA)可能在 NASH 的发病机制中发挥重要作用。我们旨在确定血清 IgA 浓度是否可以诊断 NASH 患者的肝纤维化。

方法

我们比较了 108 例 NASH 分期 0-2 期和 19 例 NASH 分期 3 期患者的血清 IgA 浓度。

结果

在单因素分析中,年龄(P < 0.0001)、性别(P = 0.0039)、血清白蛋白水平(P = 0.0192)、AST(P < 0.0001)、AST/ALT 比值(P < 0.0001)、血小板计数(P = 0.0027)、透明质酸水平(P < 0.0001)、空腹血糖(FBS)(P = 0.0013)、IRI(P = 0.0001)、凝血酶原时间(%)(P = 0.0287)、IgA(P < 0.0001)、IgG、IgA 和 IgM 的总总和(P = 0.0049)和 IgA/(IgG + IgA + IgM)(P = 0.0105)在重度 NASH 患者中显著高于早期 NASH 组。多因素 logistic 回归分析显示,在重度 NASH 患者中,只有血清 IgA 浓度显著升高(P = 0.0225),与早期 NASH 患者相比。与早期 NASH 相比,血清 IgA 浓度的曲线下面积(AUC)为 0.758,用于检测重度 NASH。

结论

血清 IgA 浓度可能是评估 NASH 肝硬化前进展的有用独立预测因子。

相似文献

1
Serum immunoglobulin a concentration is an independent predictor of liver fibrosis in nonalcoholic steatohepatitis before the cirrhotic stage.血清免疫球蛋白 A 浓度是非酒精性脂肪性肝炎肝硬化前阶段肝纤维化的独立预测因子。
Dig Dis Sci. 2011 Dec;56(12):3648-54. doi: 10.1007/s10620-011-1771-2. Epub 2011 Jun 15.
2
Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease.血清免疫球蛋白A浓度是非酒精性脂肪性肝病中肝纤维化的可靠生物标志物。
World J Gastroenterol. 2014 Sep 21;20(35):12566-73. doi: 10.3748/wjg.v20.i35.12566.
3
Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease.血清免疫球蛋白水平可预测非酒精性脂肪性肝病患者的纤维化程度。
J Hepatol. 2014 May;60(5):1055-62. doi: 10.1016/j.jhep.2014.01.010. Epub 2014 Jan 18.
4
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).丙氨酸氨基转移酶水平对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎(NASH)和肝纤维化的预测价值。
Liver Int. 2013 Oct;33(9):1398-405. doi: 10.1111/liv.12226. Epub 2013 Jun 13.
5
Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage?红细胞分布宽度增加是否是非酒精性脂肪性肝炎和纤维化阶段的标志物?
World J Gastroenterol. 2013 Nov 14;19(42):7412-8. doi: 10.3748/wjg.v19.i42.7412.
6
A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.用于非酒精性脂肪性肝炎 (NASH) 和 NASH 相关纤维化的生物标志物组合。
Obes Surg. 2011 Apr;21(4):431-9. doi: 10.1007/s11695-010-0204-1.
7
Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful?非酒精性脂肪性肝炎与酒精性脂肪性肝炎的鉴别:常规实验室指标有用吗?
Wien Klin Wochenschr. 2008;120(1-2):25-30. doi: 10.1007/s00508-007-0921-1.
8
Plasma free myristic acid proportion is a predictor of nonalcoholic steatohepatitis.血浆游离肉豆蔻酸比例是预测非酒精性脂肪性肝炎的指标。
Dig Dis Sci. 2011 Oct;56(10):3045-52. doi: 10.1007/s10620-011-1712-0. Epub 2011 Apr 23.
9
The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease.生物标志物和非酒精性脂肪性肝炎临床研究网络肝脏活检评分系统在非酒精性脂肪性肝病患者中的临床应用
J Gastroenterol Hepatol. 2009 Apr;24(4):564-8. doi: 10.1111/j.1440-1746.2008.05731.x.
10
Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis.循环微颗粒作为丙型肝炎或非酒精性脂肪性肝炎患者炎症严重程度的疾病特异性生物标志物。
Gastroenterology. 2012 Aug;143(2):448-58. doi: 10.1053/j.gastro.2012.04.031. Epub 2012 Apr 24.

引用本文的文献

1
Mini-review: Serum immunoglobulins and MASLD.小型综述:血清免疫球蛋白与代谢相关脂肪性肝病
Front Immunol. 2025 Aug 15;16:1655560. doi: 10.3389/fimmu.2025.1655560. eCollection 2025.
2
Serum immunoglobulin A levels: Diagnostic utility in alcoholic liver disease and association with liver fibrosis in steatotic liver disease.血清免疫球蛋白A水平:在酒精性肝病中的诊断效用及与脂肪性肝病肝纤维化的关联
Biomed Rep. 2024 Aug 1;21(4):142. doi: 10.3892/br.2024.1830. eCollection 2024 Oct.
3
Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD).

本文引用的文献

1
Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Toll-like receptor 9 activation.酒精性肝硬化中免疫球蛋白A升高:探索B细胞对Toll样受体9激活的反应
Clin Exp Immunol. 2009 Oct;158(1):115-24. doi: 10.1111/j.1365-2249.2009.04004.x.
2
Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities.普通成年人群血清免疫球蛋白(IgG、IgA、IgM)水平及其与饮酒、吸烟和常见代谢异常的关系。
Clin Exp Immunol. 2008 Jan;151(1):42-50. doi: 10.1111/j.1365-2249.2007.03545.x. Epub 2007 Nov 15.
3
打破障碍:肠道内稳态在代谢相关脂肪性肝病(MASLD)中的作用。
Gut Microbes. 2024 Jan-Dec;16(1):2331460. doi: 10.1080/19490976.2024.2331460. Epub 2024 Mar 21.
4
Intestinal Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病发病机制中的肠道屏障功能
J Clin Transl Hepatol. 2023 Apr 28;11(2):452-458. doi: 10.14218/JCTH.2022.00089. Epub 2022 Aug 22.
5
Serum immunoglobulin A levels and non-alcoholic fatty liver disease.血清免疫球蛋白A水平与非酒精性脂肪性肝病
Can Liver J. 2018 Dec 25;1(4):248-255. doi: 10.3138/canlivj.2018-0005. eCollection 2018 Fall.
6
Determination of antibodies in everyday rheumatological practice.日常风湿病学实践中抗体的测定。
Reumatologia. 2019;57(2):91-99. doi: 10.5114/reum.2019.84814. Epub 2019 Apr 29.
7
Serum Immunoglobulin A Levels Do Not Correlate With Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease.血清免疫球蛋白 A 水平与儿科非酒精性脂肪性肝病的肝病严重程度无关。
J Pediatr Gastroenterol Nutr. 2018 Nov;67(5):631-634. doi: 10.1097/MPG.0000000000002104.
8
Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis.诊断时年龄对原发性硬化性胆管炎患者疾病进展的影响。
United European Gastroenterol J. 2018 Mar;6(2):255-262. doi: 10.1177/2050640617717156. Epub 2017 Jun 17.
9
Immunoglobulin A and liver diseases.免疫球蛋白 A 与肝脏疾病。
J Gastroenterol. 2018 Jun;53(6):691-700. doi: 10.1007/s00535-017-1400-8. Epub 2017 Oct 26.
10
Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease.识别氧化特异性表位的低水平IgM抗体与人类非酒精性脂肪性肝病相关。
BMC Med. 2016 Jul 22;14(1):107. doi: 10.1186/s12916-016-0652-0.
Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease.
代谢综合征饮食的比较综述:对非酒精性脂肪性肝病的影响
Am J Clin Nutr. 2007 Aug;86(2):285-300. doi: 10.1093/ajcn/86.2.285.
4
Fatty liver and the metabolic syndrome.脂肪肝与代谢综合征
Curr Opin Gastroenterol. 2007 Mar;23(2):193-8. doi: 10.1097/MOG.0b013e32801421a9.
5
The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve.使用基于受试者工作特征曲线的两个标准所获得的“最佳”切点的不一致性。
Am J Epidemiol. 2006 Apr 1;163(7):670-5. doi: 10.1093/aje/kwj063. Epub 2006 Jan 12.
6
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.代谢综合征作为非酒精性脂肪性肝病的预测指标。
Ann Intern Med. 2005 Nov 15;143(10):722-8. doi: 10.7326/0003-4819-143-10-200511150-00009.
7
The natural history of nonalcoholic fatty liver disease: a population-based cohort study.非酒精性脂肪性肝病的自然史:一项基于人群的队列研究。
Gastroenterology. 2005 Jul;129(1):113-21. doi: 10.1053/j.gastro.2005.04.014.
8
Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells.人血清免疫球蛋白A的免疫调节特性:在人单核细胞和外周血单核细胞中的抗炎和促炎活性
Clin Exp Immunol. 2005 Jun;140(3):478-90. doi: 10.1111/j.1365-2249.2005.02779.x.
9
Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者肝纤维化生化标志物的临床应用价值
World J Gastroenterol. 2005 Jan 14;11(2):255-9. doi: 10.3748/wjg.v11.i2.255.
10
Index for rating diagnostic tests.诊断试验评级指数。
Cancer. 1950 Jan;3(1):32-5. doi: 10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3.